Skip To Main Content
Kimitsu Chuo Byoin on Muck Rack

Kimitsu Chuo Byoin

As seen in: Wiley Online Library, BJU International Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kimitsu Chuo

Contact Kimitsu Chuo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate Cancer

|
By Kimitsu Chuo Byoin, Satoshi Yamamoto, Koichiro Kurokawa
| Wiley Online Library Verified
Conflicts of Interest Kimitsu Chuo Byoin has received institutional clinical trial funding from Eli Lilly Japan K.K. and AstraZeneca K.K. The present study did not receive any specific funding from these companies. Kazuyoshi Nakamura has received research grants from AstraZeneca, Eli Lilly & Company, Johnson & Johnson, and Tsumura, and lecture fees from Astellas Pharma, AstraZeneca, Bayer, Johnson & Johnson, and Takeda Pharmaceutical.
Open in Who Shared Issue with article?

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis

|
By Yasutaka Yamada, Kodai Sato, Kimitsu Chuo Byoin, Tomoki Shirafuji
| BJU International Journal Verified
Opens in a new window Opens an external website Opens an external website in a new window To improve your experience, we (and our partners) store and/or access information on your terminal (cookie or equivalent) with your consent for all our websites and applications, on your connected terminals.
Open in Who Shared View Duplicates (694) Issue with article?
See all 2 articles